Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A study from the Radcliffe Department of Medicine has found that the Athena SWAN scheme tackles multiple factors more comprehensively than other initiatives.

Circular diagram showing Athena Swan domains

Established in the UK in 2005 to encourage and recognise commitment to advancing the careers of women in science, technology, engineering, maths and medicine, Athena SWAN is now widely adopted in the UK and has spread globally. Despite the widespread adoption of Athena SWAN, there is a paucity of research on the design and implementation of Athena SWAN action plans.

So, a team of researchers from Aarhus University, RDM, and the NIHR Oxford Biomedical Research Centre analysed the design and implementation of 16 departmental Athena SWAN Silver action plans in the Medical Sciences Division of the University of Oxford.

The study showed that Athena SWAN is the single most comprehensive gender equality scheme in Europe. RDM’s Pavel Ovseiko explained: “Given that the complex mix of factors produces barriers for women in science, an equally complex intervention is required to address them. Athena SWAN does this more comprehensively than any other single scheme in Europe by focusing systemic interventions on all genders, career stages, and categories of staff. Yet, Athena SWAN can be further strengthened based on Europe’s best practice of Responsible Research and Innovation in promoting the integration of sex and gender analysis in research and education”.

The study interpreted these empirical findings using complexity theory and showed that Athena SWAN Silver action plans conform to the key considerations of complexity such as having multiple actions and areas of intervention, focusing on the local dynamics, the non-linearity of interventions, and the constantly emerging conditions.

Read the full story on the Radcliffe Department of Medicine website

Find out more about Athena SWAN in the Medical Sciences Division

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.